Heller C, Bachmann I, Spiegel M, Hufert F, Dame G
Microorganisms. 2024; 12(7).
PMID: 39065054
PMC: 11278521.
DOI: 10.3390/microorganisms12071285.
Mhaya A, Begu D, Tounsi S, Arpin C
Antimicrob Agents Chemother. 2020; 64(6).
PMID: 32253218
PMC: 7269514.
DOI: 10.1128/AAC.00128-20.
Sivalingam P, Pote J, Prabakar K
Pathogens. 2019; 8(4).
PMID: 31581701
PMC: 6963203.
DOI: 10.3390/pathogens8040174.
Singha M, Kumar G, Jain D, Kumar N G, Ray D, Ghosh A
ACS Omega. 2019; 4(6):10891-10898.
PMID: 31460186
PMC: 6648899.
DOI: 10.1021/acsomega.9b01145.
Lin Y, Abdul Rahim N, Zhao J, Han M, Yu H, Wickremasinghe H
Antimicrob Agents Chemother. 2019; 63(4).
PMID: 30670431
PMC: 6437486.
DOI: 10.1128/AAC.02176-18.
Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods.
Lee C, Lee J, Park K, Kim Y, Jeong B, Lee S
Front Microbiol. 2016; 7:895.
PMID: 27379038
PMC: 4904035.
DOI: 10.3389/fmicb.2016.00895.
Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two 'old' antibiotics-polymyxin B and chloramphenicol.
Abdul Rahim N, Cheah S, Johnson M, Yu H, Sidjabat H, Boyce J
J Antimicrob Chemother. 2015; 70(9):2589-97.
PMID: 26023209
PMC: 4635649.
DOI: 10.1093/jac/dkv135.
Membrane-active macromolecules resensitize NDM-1 gram-negative clinical isolates to tetracycline antibiotics.
Uppu D, Manjunath G, Yarlagadda V, Kaviyil J, Ravikumar R, Paramanandham K
PLoS One. 2015; 10(3):e0119422.
PMID: 25789871
PMC: 4366164.
DOI: 10.1371/journal.pone.0119422.
Discovery of novel new Delhi metallo-β-lactamases-1 inhibitors by multistep virtual screening.
Wang X, Lu M, Shi Y, Ou Y, Cheng X
PLoS One. 2015; 10(3):e0118290.
PMID: 25734558
PMC: 4348537.
DOI: 10.1371/journal.pone.0118290.
A high-resolution genomic analysis of multidrug-resistant hospital outbreaks of Klebsiella pneumoniae.
Chung The H, Karkey A, Thanh D, Boinett C, Cain A, Ellington M
EMBO Mol Med. 2015; 7(3):227-39.
PMID: 25712531
PMC: 4364942.
DOI: 10.15252/emmm.201404767.
Carbapenemase-producing Enterobacteriaceae.
Doi Y, Paterson D
Semin Respir Crit Care Med. 2015; 36(1):74-84.
PMID: 25643272
PMC: 4470611.
DOI: 10.1055/s-0035-1544208.
Phenotypic and molecular characteristics of carbapenem-resistant Enterobacteriaceae in a health care system in Los Angeles, California, from 2011 to 2013.
Pollett S, Miller S, Hindler J, Uslan D, Carvalho M, Humphries R
J Clin Microbiol. 2014; 52(11):4003-9.
PMID: 25210072
PMC: 4313239.
DOI: 10.1128/JCM.01397-14.
"Stormy waters ahead": global emergence of carbapenemases.
Patel G, Bonomo R
Front Microbiol. 2013; 4:48.
PMID: 23504089
PMC: 3596785.
DOI: 10.3389/fmicb.2013.00048.
Treatment of complicated urinary tract infections with an emphasis on drug-resistant gram-negative uropathogens.
Levison M, Kaye D
Curr Infect Dis Rep. 2013; 15(2):109-15.
PMID: 23378123
DOI: 10.1007/s11908-013-0315-7.
Emergence of OXA-48 and OXA-181 carbapenemases among Enterobacteriaceae in South Africa and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract.
Brink A, Coetzee J, Corcoran C, Clay C, Hari-Makkan D, Jacobson R
J Clin Microbiol. 2012; 51(1):369-72.
PMID: 23152549
PMC: 3536210.
DOI: 10.1128/JCM.02234-12.